Ivermectin taken at the start of pregnancy is not associated with an increased risk of adverse pregnancy outcomes

A study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by the "la Caixa" Foundation, found no increased risk of miscarriage, stillbirth or major congenital anomalies among women inadvertently exposed to ivermectin from two weeks before conception through the fi